Natural α-Glucosidase and Protein Tyrosine Phosphatase 1B Inhibitors: A Source of Scaffold Molecules for Synthesis of New Multitarget Antidiabetic Drugs

Overview

Journal Molecules

Publisher MDPI

Specialty Biology

Date 2021 Aug 27

PMID 34443409

Citations 11

Authors

Massimo Genovese

Ilaria Nesi

Anna Caselli

Paolo Paoli

Affiliations

Soon will be listed here.

Abstract

Diabetes mellitus (DM) represents a group of metabolic disorders that leads to acute and long-term serious complications and is considered a worldwide sanitary emergence. Type 2 diabetes (T2D) represents about 90% of all cases of diabetes, and even if several drugs are actually available for its treatment, in the long term, they show limited effectiveness. Most traditional drugs are designed to act on a specific biological target, but the complexity of the current pathologies has demonstrated that molecules hitting more than one target may be safer and more effective. The purpose of this review is to shed light on the natural compounds known as α-glucosidase and Protein Tyrosine Phosphatase 1B (PTP1B) dual-inhibitors that could be used as lead compounds to generate new multitarget antidiabetic drugs for treatment of T2D.

Citing Articles

Synthesis, α-Glucosidase, α-Amylase, and Aldol Reductase Inhibitory Activity with Molecular Docking Study of Novel Imidazo[1,2-]pyridine Derivatives.

Kaya B, Acar Cevik U, Ciftci B, Duran H, Turkes C, Isik M ACS Omega. 2024; 9(42):42905-42914.

PMID: 39464438 PMC: 11500159. DOI: 10.1021/acsomega.4c05619.

Protein Tyrosine Phosphatase 1B Inhibitors of Based on the Spectrum-Effect Relationship by Q-Marker Selection.

Zhang Y, Liu H, Lv T, Xiao M, Gao G Molecules. 2024; 29(12).

PMID: 38930797 PMC: 11207073. DOI: 10.3390/molecules29122731.

Isolation, invitro, invivo anti-inflammatory, analgesic and antioxidant potential of Habenaria plantegania Lindl.

Alshehri O, Shabnam M, Ahmed Asiri S, Mahnashi M, Sadiq A, Jan M Inflammopharmacology. 2024; 32(2):1353-1369.

PMID: 38334860 DOI: 10.1007/s10787-023-01425-4.

Anti-Diabetic Activity of Glycyrrhetinic Acid Derivatives FC-114 and FC-122: Scale-Up, In Silico, In Vitro, and In Vivo Studies.

Alvarez-Almazan S, Solis-Dominguez L, Duperou-Luna P, Fuerte-Gomez T, Gonzalez-Andrade M, Aranda-Barradas M Int J Mol Sci. 2023; 24(16).

PMID: 37628991 PMC: 10454726. DOI: 10.3390/ijms241612812.

α-Glucosidase Inhibitors from Two Mangrove-Derived Actinomycetes.

Lu X, Zhang M, Qiu Y, Liu X, Wang C, Chen J Molecules. 2023; 28(9).

PMID: 37175232 PMC: 10180428. DOI: 10.3390/molecules28093822.

References

Paoli P, Cirri P, Caselli A, Ranaldi F, Bruschi G, Santi A . The insulin-mimetic effect of Morin: a promising molecule in diabetes treatment. Biochim Biophys Acta. 2013; 1830(4):3102-11. DOI: 10.1016/j.bbagen.2013.01.017. View

Islam M, Jung H, Sohn H, Kim H, Choi J . Potent α-glucosidase and protein tyrosine phosphatase 1B inhibitors from Artemisia capillaris. Arch Pharm Res. 2013; 36(5):542-52. DOI: 10.1007/s12272-013-0069-7. View

Seong S, Roy A, Jung H, Jin Jung H, Choi J . Protein tyrosine phosphatase 1B and α-glucosidase inhibitory activities of Pueraria lobata root and its constituents. J Ethnopharmacol. 2016; 194:706-716. DOI: 10.1016/j.jep.2016.10.007. View

Shinde R, Kumar G, Eqbal S, Sobhia M . Screening and identification of potential PTP1B allosteric inhibitors using in silico and in vitro approaches. PLoS One. 2018; 13(6):e0199020. PMC: 6005499. DOI: 10.1371/journal.pone.0199020. View

Ferhati X, Matassini C, Fabbrini M, Goti A, Morrone A, Cardona F . Dual targeting of PTP1B and glucosidases with new bifunctional iminosugar inhibitors to address type 2 diabetes. Bioorg Chem. 2019; 87:534-549. DOI: 10.1016/j.bioorg.2019.03.053. View

Ali M, Jannat S, Jung H, Choi J . Insulin-Mimetic Dihydroxanthyletin-Type Coumarins from with Protein Tyrosine Phosphatase 1B and α-Glucosidase Inhibitory Activities and Docking Studies of Their Molecular Mechanisms. Antioxidants (Basel). 2021; 10(2). PMC: 7919472. DOI: 10.3390/antiox10020292. View

Ramachandran U, Kumar R, Mittal A . Fine tuning of PPAR ligands for type 2 diabetes and metabolic syndrome. Mini Rev Med Chem. 2006; 6(5):563-73. DOI: 10.2174/138955706776876140. View

Milligan S . Combination therapy for the improvement of long-term macrovascular and microvascular outcomes in type 2 diabetes: Rationale and evidence for early initiation. J Diabetes Complications. 2016; 30(6):1177-85. DOI: 10.1016/j.jdiacomp.2016.03.010. View

Zhang C, Geng C, Huang X, Zhang X, Chen J . Antidiabetic Stilbenes from Peony Seeds with PTP1B, α-Glucosidase, and DPPIV Inhibitory Activities. J Agric Food Chem. 2019; 67(24):6765-6772. DOI: 10.1021/acs.jafc.9b01193. View

10.

Lu B, Gu P, Xu Y, Ye X, Wang Y, Du H . Overexpression of protein tyrosine phosphatase 1B impairs glucose-stimulated insulin secretion in INS-1 cells. Minerva Endocrinol. 2015; 41(1):1-9. View

11.

Cheng C, Ku H, Lin H . PGC-1α as a Pivotal Factor in Lipid and Metabolic Regulation. Int J Mol Sci. 2018; 19(11). PMC: 6274980. DOI: 10.3390/ijms19113447. View

12.

Mphahlele M, Choong Y, Maluleka M, Gildenhuys S . Synthesis, In Vitro Evaluation and Molecular Docking of the 5-Acetyl-2-aryl-6-hydroxybenzo[]furans against Multiple Targets Linked to Type 2 Diabetes. Biomolecules. 2020; 10(3). PMC: 7175131. DOI: 10.3390/biom10030418. View

13.

Liu Y, Li Y, Zhao Y, Guo J, Liu Y, Wang X . Carbazole alkaloids from the fruits of Clausena anisum-olens with potential PTP1B and α-glucosidase inhibitory activities. Bioorg Chem. 2021; 110:104775. DOI: 10.1016/j.bioorg.2021.104775. View

14.

Yaribeygi H, Farrokhi F, Butler A, Sahebkar A . Insulin resistance: Review of the underlying molecular mechanisms. J Cell Physiol. 2018; 234(6):8152-8161. DOI: 10.1002/jcp.27603. View

15.

Morphy R, Rankovic Z . Designed multiple ligands. An emerging drug discovery paradigm. J Med Chem. 2005; 48(21):6523-43. DOI: 10.1021/jm058225d. View

16.

He X, Chen J, Li T, Zhang X, Guo Y, Zhang X . Nineteen New Flavanol-Fatty Alcohol Hybrids with α-Glucosidase and PTP1B Dual Inhibition: One Unusual Type of Antidiabetic Constituent from . J Agric Food Chem. 2020; 68(41):11434-11448. DOI: 10.1021/acs.jafc.0c04615. View

17.

Tanabe K, Nakamura S, Omagari K, Oku T . Repeated ingestion of the leaf extract from Morus alba reduces insulin resistance in KK-Ay mice. Nutr Res. 2011; 31(11):848-54. DOI: 10.1016/j.nutres.2011.09.023. View

18.

Coskun T, Sloop K, Loghin C, Alsina-Fernandez J, Urva S, Bokvist K . LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept. Mol Metab. 2018; 18:3-14. PMC: 6308032. DOI: 10.1016/j.molmet.2018.09.009. View

19.

Islam M, Choi R, Jung H, Oh S, Choi J . Promising anti-diabetic potential of capillin and capillinol isolated from Artemisia capillaris. Arch Pharm Res. 2016; 39(3):340-9. DOI: 10.1007/s12272-016-0715-y. View

20.

Staels B, Rubenstrunk A, Noel B, Rigou G, Delataille P, Millatt L . Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Hepatology. 2013; 58(6):1941-52. DOI: 10.1002/hep.26461. View